These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9350056)
1. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response. Nelson PJ; Gelman IH Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056 [TBL] [Abstract][Full Text] [Related]
2. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS. Gelman IH; Lee K; Tombler E; Gordon R; Lin X Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295 [TBL] [Abstract][Full Text] [Related]
3. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468 [TBL] [Abstract][Full Text] [Related]
4. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Lin X; Gelman IH Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136 [TBL] [Abstract][Full Text] [Related]
5. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Lin X; Nelson P; Gelman IH Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843 [TBL] [Abstract][Full Text] [Related]
6. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Gelman IH; Tombler E; Vargas J Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381 [TBL] [Abstract][Full Text] [Related]
7. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. Nelson PJ; Moissoglu K; Vargas J; Klotman PE; Gelman IH J Cell Sci; 1999 Feb; 112 ( Pt 3)():361-70. PubMed ID: 9885289 [TBL] [Abstract][Full Text] [Related]
8. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. Xia W; Gelman IH Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796 [TBL] [Abstract][Full Text] [Related]
9. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. Su B; Bu Y; Engelberg D; Gelman IH J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890 [TBL] [Abstract][Full Text] [Related]
10. SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression. Coats SR; Covington JW; Su M; Pabón-Peña LM; Eren M; Hao Q; Vaughan DE J Mol Cell Cardiol; 2000 Dec; 32(12):2207-19. PubMed ID: 11112996 [TBL] [Abstract][Full Text] [Related]
11. Ligand-specific control of src-suppressed C kinase substrate gene expression. Coats SR; Pabón-Peña LM; Covington JW; Vaughan DE Biochem Biophys Res Commun; 2002 Oct; 297(5):1112-20. PubMed ID: 12372401 [TBL] [Abstract][Full Text] [Related]
12. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Lin X; Gelman IH Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772 [TBL] [Abstract][Full Text] [Related]
13. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways. Gelman IH; Gao L Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152 [TBL] [Abstract][Full Text] [Related]
14. Reexpression of the major PKC substrate, SSeCKS, correlates with the tumor-suppressive effects of SCH51344 on rat-6/src and rat-6/ras fibroblasts but not on rat-6/raf fibroblasts. Gelman IH; Xi Q; Kumar CC Ann N Y Acad Sci; 1999; 886():221-4. PubMed ID: 10667224 [No Abstract] [Full Text] [Related]
16. Interleukin-17F-induced pulmonary microvascular endothelial monolayer hyperpermeability via the protein kinase C pathway. You QH; Sun GY; Wang N; Shen JL; Wang Y J Surg Res; 2010 Jul; 162(1):110-21. PubMed ID: 19577259 [TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide induces expression of SSeCKS in rat lung microvascular endothelial cell. Cheng C; Liu H; Ge H; Qian J; Qin J; Sun L; Chen M; Yan M; Shen A Mol Cell Biochem; 2007 Nov; 305(1-2):1-8. PubMed ID: 17551670 [TBL] [Abstract][Full Text] [Related]
18. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12. Guo LW; Gao L; Rothschild J; Su B; Gelman IH J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576 [TBL] [Abstract][Full Text] [Related]
19. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Xia W; Unger P; Miller L; Nelson J; Gelman IH Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719 [TBL] [Abstract][Full Text] [Related]
20. Developmental expression of the protein kinase C substrate/binding protein (clone 72/SSeCKS) in rat testis identification as a scaffolding protein containing an A-kinase-anchoring domain which is expressed during late-stage spermatogenesis. Erlichman J; Gutierrez-Juarez R; Zucker S; Mei X; Orr GA Eur J Biochem; 1999 Aug; 263(3):797-805. PubMed ID: 10469144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]